MedWellAI, Inc. 8-K

What Happened
MedWellAI, Inc. announced on April 16, 2026 that it filed a Certificate of Amendment with the Nevada Secretary of State to amend its Certificate of Designation for Series B Convertible Preferred Stock. The amendment increases the number of authorized Series B shares from 1,000,000 to 1,500,000. The original Certificate of Designation was filed December 21, 2015 (corrected November 7, 2016), and except as amended the Certificate of Designation remains in full force.

Key Details

• Amendment filed: April 16, 2026 with the Nevada Secretary of State.
• Change: Authorized Series B Convertible Preferred Stock increased from 1,000,000 to 1,500,000 shares (an additional 500,000 shares).
• Original filings: Certificate of Designation originally filed December 21, 2015 and corrected November 7, 2016.
• Document: Full text of the Certificate of Amendment is included as Exhibit 3.1 to the 8-K.

Why It Matters
The amendment creates capacity for MedWellAI to issue up to 500,000 additional Series B convertible preferred shares in the future. The 8-K does not announce any issuance or changes to the rights/terms of the Series B other than the increased authorization. For investors, additional authorized preferred shares mean the company has more flexibility for financing or other corporate actions, which—if and when shares are issued—could affect common shareholder dilution and capital structure. Review the Certificate of Amendment (Exhibit 3.1) for full legal details.